380 Oral Aspirin Plus Ticagrelor Versus Intravenous Eptifibatide Load Prior to Emergent Carotid Artery Stenting for Mechanical Thrombectomy in Anterior Circulation Tandem Strokes

INTRODUCTION: The utility of emergent carotid artery stenting (eCAS) during mechanical thrombectomy (MT) for tandem occlusions has been well-described. Single antiplatelet therapy after eCAS in tandem occlusions prevents the risk of reperfusion hemorrhage, though the risk of in-stent occlusion remains, and the optimal antiplatelet strategy remains unexplored. METHODS: Retrospective cohort study analyzing an institutional MT database. Patients were dichotomized into those receiving oral aspirin/ticagrelor load (DAPT cohort) versus intravenous eptifibatide load (Integrilin cohort) prior to eCAS during MT for tandem occlusions. Patient demographics, thrombectomy details, in-hospital course, and follow-up outcomes were compared. RESULTS: We included 138 patients with anterior circulation tandem strokes and baseline mRS 0-2. There were no differences in baseline demographics. The Integrilin cohort had more patients undergoing MT via radial access (30.4%-vs-8.7%, p=0.009) and more patients undergoing retrograde eCAS (34.8%-vs-13%, p=0.027). No differences in first pass (TICI2C-3) or modified first pass (TICI2b-3) effect rate were observed between the cohorts, through anterograde or retrograde approaches, after all passes (2.22±1.38-vs-1.58±0.95, p=0.008). Both had comparable procedural and fluoroscopy duration (p>0.05). No difference in intraprocedural stent occlusion was observed. Patients in the DAPT cohort had lower rates of post-procedure stent occlusion up to day 7 compared to those in the Integrilin cohort (5.2%-vs-30.4%, OR:0.126[0.038-0.422], p<0.001). No difference in symptomatic or asymptomatic hemorrhage rates were observed-post procedure. There were no differences in mRS 0-1, 0-2 or 0-3 at day 7, discharge, or 90 days between the treatment groups. CONCLUSIONS: Our study demonstrates that loading with aspirin/ticagrelor significantly reduces the rate of post-procedural in-stent occlusion in the short term. These results can inform practice patterns for these difficult conditions and hope to validate the findings in a multi-institution series.

Authors

Publication Details

Journal
Neurosurgery
Published
2025-03-14
DOI
https://doi.org/10.1227/neu.0000000000003360_380
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

380 Oral Aspirin Plus Ticagrelor Versus Intravenous Eptifibatide Load Prior to Emergent Carotid Artery Stenting for Mechanical Thrombectomy in Anterior Circulation Tandem Strokes

Shashwat Shah, Marissa Kruk, Elad I. Levy, Mehdi Bouslama et al.
Neurosurgery
Cerebrovascular and Carotid Artery Diseases
article

380 Oral Aspirin Plus Ticagrelor Versus Intravenous Eptifibatide Load Prior to Emergent Carotid Artery Stenting for Mechanical Thrombectomy in Anterior Circulation Tandem Strokes

Shashwat Shah, Marissa Kruk, Elad I. Levy, Mehdi Bouslama, Kunal P. Raygor, Vinay Jaikumar, Kenneth Vincent Snyder, Hamid Sharif Khan, Tyler Scullen, Jason Davies, Rosalind Lai, Isabelle Stockman, Adnan Hussai, Blake Housely
article en

Abstract

INTRODUCTION: The utility of emergent carotid artery stenting (eCAS) during mechanical thrombectomy (MT) for tandem occlusions has been well-described. Single antiplatelet therapy after eCAS in tandem occlusions prevents the risk of reperfusion hemorrhage, though the risk of in-stent occlusion remains, and the optimal antiplatelet strategy remains unexplored. METHODS: Retrospective cohort study analyzing an institutional MT database. Patients were dichotomized into those receiving oral aspirin/ticagrelor load (DAPT cohort) versus intravenous eptifibatide load (Integrilin cohort) prior to eCAS during MT for tandem occlusions. Patient demographics, thrombectomy details, in-hospital course, and follow-up outcomes were compared. RESULTS: We included 138 patients with anterior circulation tandem strokes and baseline mRS 0-2. There were no differences in baseline demographics. The Integrilin cohort had more patients undergoing MT via radial access (30.4%-vs-8.7%, p=0.009) and more patients undergoing retrograde eCAS (34.8%-vs-13%, p=0.027). No differences in first pass (TICI2C-3) or modified first pass (TICI2b-3) effect rate were observed between the cohorts, through anterograde or retrograde approaches, after all passes (2.22±1.38-vs-1.58±0.95, p=0.008). Both had comparable procedural and fluoroscopy duration (p>0.05). No difference in intraprocedural stent occlusion was observed. Patients in the DAPT cohort had lower rates of post-procedure stent occlusion up to day 7 compared to those in the Integrilin cohort (5.2%-vs-30.4%, OR:0.126[0.038-0.422], p<0.001). No difference in symptomatic or asymptomatic hemorrhage rates were observed-post procedure. There were no differences in mRS 0-1, 0-2 or 0-3 at day 7, discharge, or 90 days between the treatment groups. CONCLUSIONS: Our study demonstrates that loading with aspirin/ticagrelor significantly reduces the rate of post-procedural in-stent occlusion in the short term. These results can inform practice patterns for these difficult conditions and hope to validate the findings in a multi-institution series.

NeurosurgeryVol. 71(Supplement_1)
Openalex Percentile: Top 93%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.